Wells Fargo’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Sell |
11,903
-2,916
| -20% | -$63.5K | ﹤0.01% | 4232 |
|
|
2025
Q1 | $274K | Buy |
14,819
+326
| +2% | +$6.03K | ﹤0.01% | 4047 |
|
|
2024
Q4 | $386K | Buy |
14,493
+4,139
| +40% | +$110K | ﹤0.01% | 3886 |
|
|
2024
Q3 | $243K | Buy |
10,354
+6,751
| +187% | +$159K | ﹤0.01% | 4065 |
|
|
2024
Q2 | $66.8K | Buy |
3,603
+372
| +12% | +$6.9K | ﹤0.01% | 4803 |
|
|
2024
Q1 | $57.7K | Buy |
+3,231
| New | +$57.7K | ﹤0.01% | 4820 |
|